Sarah Cannon Research Institute
Joshua Gordon is an experienced professional in clinical research and operations, currently serving as the Manager of Study Operations at Sarah Cannon Research Institute since December 2020. Prior to this role, Joshua held the position of Director of Clinical Research at About Skin Dermatology and DermSurgery from August 2019 to December 2020, and spent over 18 years at Kaiser Permanente in various roles including Manager of Clinical Trials, Senior Research Specialist, Research Assistant, and Pharmacy Clerk. Joshua's educational background includes multiple degrees in Public Health and History from the University of Colorado Anschutz Medical Campus and the University of Colorado Boulder, including a Master's in Public Health.
This person is not in any offices
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.